Contact UsBiological Products
> Biopharmaceutical Industry Insight & News > Biological Products
| Product | Boryung DTaP Vaccine(Injection)(Pre-filled Syringe) | Company | Boryung Biopharma Co., Ltd. |
|---|---|---|---|
| Classification | Vaccine | Active Ingredient | Purified Diphtheria toxoid (Corynebacterium diphtheriae Park-Williams No. 8 Strain) Purified Tetanus toxoid (Clostridium tetani Harvard A-47Strain) Purified protective antigens of pertussis (Bordetella pertussis, Tohama1 Strain) |
| Reference Product | Approval Date | 2014 | |
| Indication | Prevention of diphtheria, tetanus and pertussis |
||
| Description |
Boryung DTaP Vaccine(Injection) is prepared by liquids containing protective antigen fractions of bordetella pertussis, diphtheria toxoid and tetanus toxoid, which is filled into a pre-filled syringe.
|
||
Korea Biomedicine Industry Association(KoBIA)
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
COPYRIGHT BY KoBIA. ALL RIGHTS RESERVED.